Диссертация (1140661), страница 17
Текст из файла (страница 17)
Holzle E, Jansen T, Plewig G. Morbigan disease – chronic persistenterythema and edema of the face. //Hautarzt 1995 Nov; 46(11):796 – 8.60. Jansen T. Clinical pesentations and classification of rosacea.//AnnDermatol Venerol 2011 Nov; 138: 192-200.61. Jansen Т., Plewig G., Kligman A.M.
Diagnosis and treatment of rosaceafulminans. //Dermatology 1994; 188 (4): 251-4.62. Jansen T., Plewig G. Rosacea: classification and treatment.//J R Soc Med1997, 90(3): 144-50.63. Jang YH, Sim JH, Kang HY еt al. Immunohistochemical expression ofmatrix metalloproteinases in the granulomatous rosacea compared with thenon-granulomatous rosacea. //J Eur Acad Dermatol Venereol. 2011May;25(5):544-8.64. Jones D. Rosacea, Reactive Oxygen Species, and Azelaic Acid.//J ClinAesthet Dermatol.2009 January; 2(1): 26–30.65.
Jun Hyung Kim, M.D., Seung Ho Chang, M.D.,1 Mi Kyung Cho, M.D.,1and Bang Soon Kim, M.D. Novel Photopneumatic Therapy for theTreatment of Rosacea. //Ann Dermatol. 2009 Aug;21(3):268-73.14166. KheirkhahA, CasasV, LiW, RajuVK, TsengSC.Cornealmanifestations of ocular demodex infestation.//Am J Ophthalmol. 2007May;143(5):743-749.67. Koca R, Altinyazar HC, Ankarali H, Muhtar S, Tekin NS, Cinar S. Acomparison of metronidazole 1% cream and pimecrolimus 1% cream inthe treatment of patients with papulopustular rosacea: randomized openlabel clinical trial. //Clin Exp Dermatol.
2010 Apr;35(3):251-6.68. Korting НС, Schöllmann С. Current topical and systemic approaches totreatment of rosacea. //J Eur Acad Dermatol, 2009;23: 876-882.69. Levin J. A Guide to the Ingredients and Potential Benefits of Over-theCounter Cleansers and Moisturizers for Rosacea Patients.//J Clin AesthetDermatol. 2011 August; 4(8): 31–49.70. LiJ, O'ReillyN, Sheha H, Katz R, Raju VK, Kavanagh K, Tseng SC.CorrelationbetweenimmunoreactivitytoocularDemodexBacillusproteinsinfestationinpatientsandserumwithFacialrosacea.//Ophthalmology.
2010 May;117(5):870-877.71. Lim SW, Lim SW, Bekhor P. Rhinophyma: Carbon dioxide laser withcomputerized scanner is still an outstanding treatment.//Australas JDermatol.2009 Nov;50(4):289-93.72. Maddin S. A comparison of topical azelaic acid 20% cream and topicalmetronidazole 0.75% cream in the treatment of patients withpapulopustular rosacea. //J Am AcadDermatol. 1999 Jun;40(6 Pt 1):961-5.73. Moravvej H, Dehghan-Mangabadi M, Abbasian M R, Meshkat-Razavi G.Associationofrosaceawithdemodicosis.//ArchIranMed.2007Apr;10(2):199-203.74.
Moreira A, Leite I, Guedes R, Baptista A, Mota G. Surgical treatment ofrhinophyma using carbon dioxide (CO2) laser and pulsed dye laser(PDL).//J CosmetLaserTher. 2010 Apr;12(2):73-6.75. Pabby A, An KP, Laws RA. Combination therapy of tetracycline andtacrolimus resulting in rapid resolution of steroid-induced periocularrosacea.//Cutis. 2003 Aug;72(2):141-2.14276. Park H., Del Rosso J. Use of Oral Isotretinoin in the Management ofRosacea.//J Clin Aesthet Dermatol.
2011 September; 4(9): 54–61.77. Payne WG, Ko F, Anspaugh S, Wheeler CK, Wright TE, Robson MC.Down-regulating causes of fibrosis with tamoxifen: a possiblecellular/molecular approach to treat rhinophyma.//Ann Plast Surg. 2006Mar;56(3):301-5.78. Pfeffer I, Borelli C, Zierhut M, Schaller M. Treatment of ocular rosaceawith 40 mg doxycycline in a slow release form.//J Dtsch DermatolGes. 2011 Jun 15.79. Preisz K, Kárpáti S. Rosacea: pathogenesis, clinical forms andtherapy.//Orv Hetil. 2010 Jul 25;151(30):1209-14.80.
Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, DavisLS. Ocular rosacea. Signs, symptoms, and tear studies before and aftertreatment with doxycycline.//Arch Dermatol. 1997 Jan;133(1):49-54.81. Ruzicka T, Assmann T, Lebwohl M. Potential future dermatologicalindications for tacrolimus ointment. //Eur J Dermatol. 2003 JulAug;13(4):331-42.82. Salamon M, Sysa-Jedrzejowska A, Lukamowicz J, Lukamowicz M,Swiatkowska E, Wozniacka A. Concentration of selected cytokines inserum of patients with acne rosacea.
//Przegl Lek. 2008;65(9):371-4.83. Sanchez J L, Berlingeri-Ramos A C, Dueno DV. Granulomatous rosacea.//Am J Dermatopathol 2008, Feb:30(1): 6-9.84. Schechter BA, Katz RS, Friedman LS. Efficacy of topical cyclosporinefor the treatment of ocular rosacea. //Adv Ther. 2009 Jun;26(6):651-9.85. Schram А., James W. Neurogenic Rosacea Treated With EndoscopicThoracic Sympathectomy. //Arch Dermatol. 2012;148(2):270-271.86. Sehgal VN, Srivastava G, Dogra S. Tacrolimus: approved andunapproved dermatologic indications/uses-physician's sequential literaturesurvey: part II.
//Skinmed. 2008 Mar-Apr;7(2):73-7.14387. Smith J., Lanier V., Braziel R. Et al. Expression of vascular endothelialgrowth factor and its receptors in rosacea.// Br J Ophthalmol.2007February; 91(2): 226–229.88. Spirov G, Berova N, Vassilev D. Effect of oral inhibitors of ovulation intreatment of rosacea and dermatitis perioralis in women.//Australas JDermatol. 1971 Dec;12:145-54.89. Ta CN, Shine WE, McCulley JP, Pandya A, Trattler W, Norbury JW.Effects of minocycline on the ocular flora of patients with acne rosacea orseborrheic blepharitis.//Cornea.
2003 Aug;22(6):545-8.90. TanziEL, WeinbergJM.Theocularmanifestationsofrosacea.//Cutis. 2001 Aug;68(2):112-4.91. TismaVS, Basta-JuzbasicA, Jaganjac M, Brcic L, Dobric I, Lipozencic J,Tatzber F, Zarkovic N, Poljak-Blazi M. Oxidative stress and ferritinexpression in the skin of patients with rosacea. //J Am Acad Dermatol.2009 Feb;60(2):270-6.92. Yamasaki К, Gallo R. The molecular pathology of rosacea.//J DermatolSci.
2009,55(2), 77–81.93. Yamasaki K., Kanada K.,Macleod D.T., Borkowski A.W., Morizane S.,Nakatsuji T., Cogen A., Gallo R. TLR2 Expression Is Increased inRosacea and Stimulates Enhanced Serine Protease Production byKeratinocytes.//J Invest Dermatol. 2011 March; 131(3): 688–697.94. Yaylali V, Ozyurt C. Comparison of tear function tests and impressioncytologywiththeocularfindingsinacnerosacea.//EurJOphthalmol. 2002 Jan-Feb;12(1):11-7.95.
You In Bae, Sook-Jung Yun, Jee-Bum Lee et al. Clinical Evaluation of168 Korean Patients with Rosacea: The Sun Exposure Correlates with theErythematotelangiectatic Subtype.//Ann Dermatol. 2009 August; 21(3):243–249.96. Valentín S., Morales A., Sánchez J L, Rivera A.
Safety and efficacy ofdoxycycline in the treatment of rosacea.//Clin Cosmet Investig Dermatol.2009; 2: 129–140.14497. Utine CA, Stern M, Akpek EK. Clinical review: topical ophthalmic use ofcyclosporin A.//Ocul Immunol Inflamm. 2010 Oct;18(5):352-61.98. Wilkin J, Dahi M, Detmar M et al.
Standart classification of rosacea:Report of the National Rosacea Society Expert Committee on theclassification and staging of rosacea. //J Am Acad Dermatol 2009; 46(4):584-7.99. Wilkin J.K. Rosacea: pathophysiology and treatment.//Arch Dermatol1994; 130: 359-62.100.Woo DK, James WD. Topical tacrolimus: a review of its uses indermatology. //Dermatitis. 2005 Mar;16 (1):6-21.145.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
